Wilbanks Smith & Thomas Asset Management LLC Haemonetics Corp Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$90.66 - $116.63 $9,066 - $11,663	-100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $8,996 - $11,458	100 New	100 $11,000

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

Capital Research Global Investors Los Angeles, CA

6.92M
Shares

$540 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.96M
Shares

$465 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.14M
Shares

$401 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

3.84M
Shares

$300 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

3.83M
Shares

$299 Million
0.27% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.01B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account